Texas Oncology-Bedford is a clinical research site located in Bedford, Texas, United States.
Crixeo Health Trust Score: 76/100 (FAIR). This profile has not yet been claimed by the site owner.
Texas Oncology-Bedford has participated in 8 clinical trials with 3 currently active.
Therapeutic areas: Tumors, Locally Recurrent Breast Cancer, Metastatic Breast Cancer.
Sponsors: Eisai Inc., Nektar Therapeutics, Daiichi Sankyo.
Trust Score: 76/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Texas Oncology-Bedford has a Crixeo Trust Score of 76/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Texas Oncology-Bedford has 8 clinical trials on record, with 3 currently active. Their work covers Tumors, Locally Recurrent Breast Cancer, Metastatic Breast Cancer.
Yes — Texas Oncology-Bedford holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.